KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Sales (2016 - 2025)

Teva Pharmaceutical Industries' Return on Sales history spans 10 years, with the latest figure at 0.1% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 19.0% year-over-year to 0.1%, compared with a TTM value of 0.08% through Dec 2025, up 21.0%, and an annual FY2025 reading of 0.08%, up 20.0% over the prior year.
  • Return on Sales for Q4 2025 was 0.1% at Teva Pharmaceutical Industries, up from 0.1% in the prior quarter.
  • The five-year high for Return on Sales was 0.1% in Q4 2023, with the low at 0.34% in Q4 2022.
  • Average Return on Sales over 5 years is 0.05%, with a median of 0.01% recorded in 2021.
  • Year-over-year, Return on Sales soared 120bps in 2021 and then tumbled -31bps in 2022.
  • Tracing TEVA's Return on Sales over 5 years: stood at 0.04% in 2021, then tumbled by -833bps to 0.34% in 2022, then surged by 130bps to 0.1% in 2023, then tumbled by -191bps to 0.09% in 2024, then surged by 205bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Return on Sales are 0.1% (Q4 2025), 0.1% (Q3 2025), and 0.07% (Q2 2025).